Motley Fool Money cover image

You Can’t Patent LSD

Motley Fool Money

00:00

Navigating the Regulatory Landscape of Psilocybin Treatments

This chapter explores the intricate regulatory framework for psilocybin treatments in the U.S., highlighting the FDA's role in the approval process and recent safety guidelines. It also touches on the hesitance of insurance companies towards coverage, as well as the implications of potential FDA approval for future treatments.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app